Sr. Director, Head of Pharmacoepidemiology @ (March 2023 - December 2023)
Sr. Director, Head Global Safety Vigilance Operations @ (April 2020 - December 2023)
Director, Global Drug Safety @ (April 2017 - October 2020)
Head Global Safety Vigilance Systems @ (October 2018 - April 2020)
Director, Drug Safety @ (November 2015 - March 2017)
Senior Safety Scientist Lead @ (January 2015 - August 2015)
Director, Drug Safety @ (December 2011 - December 2014)
Associate Director @ (January 2009 - January 2011)
Director, Drug Safety @ Cell Genesys (May 2004 - February 2009)
Manager, Drug Safety @ SangStat Medical Corporation (January 2002 - January 2004)
Pharmacy Manager @ (January 1995 - January 2000)
Craig Eng Education
University of California, San Francisco
PharmD (Pharmacy)
1988-1992
UCLA
BS (Microbiology)
1985-1988
Craig Eng Skills
Pharmacy
Oncology
Drug Safety
Clinical Development
Clinical Trials
Biotechnology
Life Sciences
GCP
Pharmaceutical Industry
Drug Development
Safety Management Systems
Customer Service
Project Management
Cell Culture
Molecular Biology
Microsoft Word
Craig Eng Summary
Craig Eng, based in San Francisco, CA, US, is currently a Sr. Director, Pharmacovigilance at 4D Molecular Therapeutics. Craig Eng brings experience from previous roles at Santen. Craig Eng holds a 1988 - 1992 PharmD in Pharmacy @ University of California, San Francisco. With a robust skill set that includes Pharmacy, Oncology, Drug Safety, Clinical Development, Clinical Trials and more. Craig Eng has 2 emails and 6 mobile phone numbers on RocketReach.
Looking for a different Craig Eng?
Find contact details for 700 million professionals.